Effects of comorbid and demographic factors on dialysis modality choice and related patient survival in Europe

Nephrology Dialysis Transplantation

Volumn 26, Issue 9, 2011, Pages 2940-2947

  Van De Luijtgaarden, Moniek W M ^a   Noordzij, Marlies ^a   Stel, Vianda S ^a   Ravani, Pietro ^b   Jarraya, Faical ^c   Collart, Frederic ^d   Schön, Staffan ^e,f   Leivestad, Torbjørn ^g   Puttinger, Heidi ^h   Wanner, Christoph ⁱ   Jager, Kitty J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF CALGARY   (Canada)

^c HEDI CHAKER HOSPITAL   (Tunisia)

^d French Speaking Belgium ESRD Registry   (Belgium)

^e Swedish Renal Registry   (Sweden)

^f Diaverum Renal Services Group   (Sweden)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

^h MEDICAL UNIVERSITY OF VIENNA   (Austria)

ⁱ UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

comorbidity; diabetes mellitus; haemodialysis; peritoneal dialysis; survival

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CEREBROVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; EUROPE; FEMALE; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; PATIENT DECISION MAKING; PERIPHERAL VASCULAR DISEASE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SURVIVAL RATE;

ADULT; AGED; COHORT STUDIES; COMORBIDITY; DEMOGRAPHY; EUROPE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PROGNOSIS; REGISTRIES; RENAL DIALYSIS; RISK FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 80053189282     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq845     Document Type: Article

References (42)

1. ERA-EDTA Registry. ERA-EDTA Registry 1998 Annual Report. Amsterdam: Academic Medical Center; 2003
2. Stel VS, Kramer A, Zoccali C et al. The 2006 ERA-EDTA Registry annual report: a precis. J Nephrol 2009; 22: 1-12
3. U.S.Renal Data System U. 2008 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive Kidney Diseases, 2008
4. Thamer M, Hwang W, Fink NE et al. US nephrologists' recommendation of dialysis modality: results of a national survey. Am J Kidney Dis 2000; 36: 1155-1165
5. Bass EB, Wills S, Fink NE et al. How strong are patients' preferences in choices between dialysis modalities and doses? Am J Kidney Dis 2004; 44: 695-705 (Pubitemid 39237614)
6. Groome PA, Hutchinson TA, Prichard SS. ESRD treatment modality selection: which factors are important in the decision? Adv Perit Dial 1991; 7: 54-56
7. Just PM, de Charro FT, Tschosik EA et al. Reimbursement and economic factors influencing dialysis modality choice around the world. Nephrol Dial Transplant 2008; 23: 2365-2373 (Pubitemid 351957587)
8. Lameire N, van Biesen W. The pattern of referral of patients with end-stage renal disease to the nephrologist-a European survey. Nephrol Dial Transplant 1999; 14 (Suppl 6): 16-23 (Pubitemid 29462210)
9. Bouvier N, Durand PY, Testa A et al. Regional discrepancies in peritoneal dialysis utilization in France: the role of the nephrologist's opinion about peritoneal dialysis. Nephrol Dial Transplant 2009; 24: 1293-1297
10. Jager KJ, Korevaar JC, Dekker FW et al. The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands. Am J Kidney Dis 2004; 43: 891-899 (Pubitemid 38529627)
11. Miskulin DC, Meyer KB, Athienites NV et al. Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease. Am J Kidney Dis 2002; 39: 324-336 (Pubitemid 34174255)
12. Stack AG. Determinants of modality selection among incident US dialysis patients: results from a national study. J Am Soc Nephrol 2002; 13: 1279-1287 (Pubitemid 34441409)
13. Couchoud C, Savoye E, Frimat L et al. Variability in case mix and peritoneal dialysis selection in fifty-nine French districts. Perit Dial Int 2008; 28: 509-517
14. Chung SH, Noh H, Ha H et al. Optimal use of peritoneal dialysis in patients with diabetes. Perit Dial Int 2009; 29 (Suppl 2): S132-S134
15. Couchoud C, Moranne O, Frimat L et al. Associations between comorbidities, treatment choice and outcome in the elderly with end-stage renal disease. Nephrol Dial Transplant 2007; 22: 3246-3254 (Pubitemid 350202562)
16. Ganesh SK, Hulbert-Shearon T, Port FK et al. Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol 2003; 14: 415-424 (Pubitemid 36150865)
17. McDonald SP, Marshall MR, Johnson DW et al. Relationship between dialysis modality and mortality. J Am Soc Nephrol 2009; 20: 155-163
18. Stack AG, Molony DA, Rahman NS et al. Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States. Kidney Int 2003; 64: 1071-1079 (Pubitemid 37013845)
19. Vonesh EF, Snyder JJ, Foley RN et al. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int 2004; 66: 2389-2401
20. Stel VS, van Dijk PC, van Manen JG et al. Prevalence of co-morbidity in different European RRT populations and its effect on access to renal transplantation. Nephrol Dial Transplant 2005; 20: 2803-2811 (Pubitemid 41672283)
21. Stel VS, Dekker FW, Ansell D et al. Residual renal function at the start of dialysis and clinical outcomes. Nephrol Dial Transplant 2009; 24: 3175-3182
22. Jager KJ, Zoccali C, Macleod A et al. Confounding: what it is and how to deal with it. Kidney Int 2008; 73: 256-260
23. Jager KJ, van Dijk PC, Zoccali C et al. The analysis of survival data: the Kaplan-Meier method. Kidney Int 2008; 74: 560-565
24. Bloembergen WE, Port FK, Mauger EA et al. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6: 177-183
25. Fitzmaurice G. Confounding: propensity score adjustment. Nutrition 2006; 22: 1214-1216 (Pubitemid 44692453)
26. Babazono T, Miyamae M, Tomonaga O et al. Cardiovascular risk factors in diabetic patients undergoing continuous ambulatory peritoneal dialysis. Adv Perit Dial 1996; 12: 120-125
27. Fassett RG, Driver R, Healy H et al. Comparison of markers of oxidative stress, inflammation and arterial stiffness between incident hemodialysis and peritoneal dialysis patients-an observational study. BMC Nephrol 2009; 10: 8
28. Locatelli F, Pozzoni P, Del Vecchio L. Renal replacement therapy in patients with diabetes and end-stage renal disease. J Am Soc Nephrol 2004; 15 (Suppl 1): S25-S29 (Pubitemid 38018450)
29. Schlieper G, Kruger T, Djuric Z et al. Vascular access calcification predicts mortality in hemodialysis patients. Kidney Int 2008; 74: 1582-1587
30. Wu HY, Hung KY, Huang JW et al. Initial glucose load predicts technique survival in patients on chronic peritoneal dialysis. Am J Nephrol 2008; 28: 765-771
31. Rumpsfeld M, McDonald SP, Johnson DW. Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol 2006; 17: 271-278
32. Churchill DN, Thorpe KE, Nolph KD et al. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1998; 9: 1285-1292 (Pubitemid 28283893)
33. Collins AJ, Hao W, Xia H et al. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 1999; 34: 1065-1074
34. Fenton SS, Schaubel DE, Desmeules M et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis 1997; 30: 334-342 (Pubitemid 27391500)
35. Liem YS, Wong JB, Hunink MG et al. Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands. Kidney Int 2007; 71: 153-158 (Pubitemid 46094689)
36. Lee CC, Sun CY, Wu MS. Long-term modality-related mortality analysis in incident dialysis patients. Perit Dial Int 2009; 29: 182-190
37. Sanabria M, Munoz J, Trillos C et al. Dialysis outcomes in Colombia (DOC) study: a comparison of patient survival on peritoneal dialysis vs hemodialysis in Colombia. Kidney Int Suppl 2008; 108: S165-S172 (Pubitemid 351466534)
38. Termorshuizen F, Korevaar JC, Dekker FW et al. Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2. J Am Soc Nephrol 2003; 14: 2851-2860 (Pubitemid 37305648)
39. Vonesh EF, Moran J. Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1999; 10: 354-365 (Pubitemid 29068076)
40. Xue JL, Everson SE, Constantini EG et al. Peritoneal and hemodialysis: II. Mortality risk associated with initial patient characteristics. Kidney Int 2002; 61: 741-746 (Pubitemid 34102618)
41. Korevaar JC, Feith GW, Dekker FW et al. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int 2003; 64: 2222-2228 (Pubitemid 37449558)
42. Heaf JG, Lokkegaard H, Madsen M. Initial survival advantage of peritoneal dialysis relative to haemodialysis. Nephrol Dial Transplant 2002; 17: 112-117 (Pubitemid 34093019)